CRISPR Therapeutics (CRSP) News Today → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free CRSP Stock Alerts $53.73 -1.92 (-3.45%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 5%marketbeat.com - April 25 at 6:18 PMCRISPR Therapeutics (NASDAQ:CRSP) Trading 0.5% Higher marketbeat.com - April 24 at 4:22 PMCrispr Therapeutics: Now Is The Time To Buyseekingalpha.com - April 24 at 12:40 PMCRISPR Therapeutics (NASDAQ:CRSP) Trading Up 4.5%marketbeat.com - April 23 at 2:58 PMCRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meetingglobenewswire.com - April 22 at 4:30 PMCRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 0.2%marketbeat.com - April 22 at 1:55 PMCRISPR Therapeutics AG (NASDAQ:CRSP) Holdings Cut by Allspring Global Investments Holdings LLCmarketbeat.com - April 22 at 4:41 AMCRISPR Therapeutics AG (NASDAQ:CRSP) Receives Consensus Rating of "Hold" from Brokeragesamericanbankingnews.com - April 22 at 3:50 AMCRISPR Therapeutics (NASDAQ:CRSP) PT Raised to $89.00americanbankingnews.com - April 20 at 2:58 AMCRISPR Therapeutics (NASDAQ:CRSP) Trading Up 0.8% Following Analyst Upgradeamericanbankingnews.com - April 20 at 2:22 AMCRISPR Therapeutics Stock (NASDAQ:CRSP) Pushes Lower, But Fundamentals Are Intactmarkets.businessinsider.com - April 20 at 12:06 AMCRISPR Therapeutics (NASDAQ:CRSP) Trading Up 0.8% on Analyst Upgrademarketbeat.com - April 19 at 11:37 AMSamarth Kulkarni Sells 19,582 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) Stockinsidertrades.com - April 19 at 5:06 AMCRISPR Therapeutics (NASDAQ:CRSP) Trading 2.8% Higher on Analyst Upgradeamericanbankingnews.com - April 19 at 1:36 AMCRISPR Therapeutics (NASDAQ:CRSP) Stock Price Up 2.8% After Analyst Upgrademarketbeat.com - April 18 at 2:47 PMCitigroup Boosts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $89.00marketbeat.com - April 18 at 1:28 PMCRISPR Therapeutics AG (NASDAQ:CRSP) CEO Samarth Kulkarni Sells 19,582 Sharesmarketbeat.com - April 17 at 6:38 PMCRISPR Therapeutics's Options Frenzy: What You Need to Knowbenzinga.com - April 17 at 6:25 PMBullish Trendline Has Never Failed Crispr Therapeutics Stockfinance.yahoo.com - April 17 at 1:25 PMIs Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now?finance.yahoo.com - April 17 at 1:25 PMCRISPR Therapeutics (NASDAQ:CRSP) Trading Down 1.8%marketbeat.com - April 17 at 12:42 PMCRISPR Therapeutics (NASDAQ:CRSP) Trading Down 1.1%marketbeat.com - April 16 at 2:35 PMCRISPR Therapeutics (NASDAQ:CRSP) Shares Down 1.5% marketbeat.com - April 15 at 3:37 PMCarnegie Capital Asset Management LLC Sells 15,180 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP)marketbeat.com - April 15 at 9:24 AMCRISPR Therapeutics AG (NASDAQ:CRSP) Shares Bought by Capital Advisors Inc. OKmarketbeat.com - April 13 at 4:52 PM3 Magnificent Stocks That Could Double or More by 2030fool.com - April 13 at 8:47 AMAsset Management One Co. Ltd. Invests $1.74 Million in CRISPR Therapeutics AG (NASDAQ:CRSP)marketbeat.com - April 13 at 5:10 AMCRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 2.1%marketbeat.com - April 12 at 2:02 PMCRISPR Therapeutics (NASDAQ:CRSP) Shares Down 0.2% marketbeat.com - April 11 at 2:28 PMWall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024investorplace.com - April 11 at 1:10 PMNeedham & Company LLC Reaffirms Buy Rating for CRISPR Therapeutics (NASDAQ:CRSP)marketbeat.com - April 11 at 8:31 AMBaillie Gifford & Co. Reduces Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)marketbeat.com - April 11 at 7:23 AMCRISPR Therapeutics AG (CRSP) Annual Needham Virtual Healthcare Conference - (Transcript)seekingalpha.com - April 10 at 3:25 PMCRISPR Therapeutics (NASDAQ:CRSP) Trading Down 5.4%marketbeat.com - April 10 at 12:58 PMCRISPR Therapeutics (NASDAQ:CRSP) Trading Up 1.3%marketbeat.com - April 9 at 12:33 PMBetter Buy: CRISPR Therapeutics Vs. Viking Therapeuticsfool.com - April 9 at 10:00 AMCRISPR Therapeutics (NASDAQ:CRSP) Shares Up 1.1%marketbeat.com - April 8 at 11:59 AMOversold Conditions For CRISPR Therapeutics (CRSP)nasdaq.com - April 7 at 10:23 PMBetter Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeuticsfool.com - April 5 at 5:03 AMCRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Knowfinance.yahoo.com - April 4 at 7:47 PMCRISPR Therapeutics (NASDAQ:CRSP) Trading 3.3% Higher marketbeat.com - April 4 at 3:27 PMCRISPR Therapeutics (NASDAQ:CRSP) Shares Down 0.1% marketbeat.com - April 3 at 3:27 PMBuy Rating Affirmed for Crispr Therapeutics AG on Promising Gene Editing Developments and Expanding Treatment Pipelinemarkets.businessinsider.com - April 3 at 10:16 AMCRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conferenceglobenewswire.com - April 3 at 8:00 AMCRISPR Therapeutics (NASDAQ:CRSP) Shares Down 4% marketbeat.com - April 2 at 3:18 PMBaker Chad R Boosts Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)marketbeat.com - April 1 at 5:44 PMCRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 0.9%marketbeat.com - April 1 at 3:49 PMCRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meetingglobenewswire.com - April 1 at 8:00 AMAre Investors Vastly Underestimating CRISPR Therapeutics Stock (NASDAQ:CRSP)?msn.com - April 1 at 3:55 AM3 Unstoppable Stocks to Buy Hand Over Fist in Aprilfool.com - March 30 at 8:14 AM Get CRISPR Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRSP and its competitors with MarketBeat's FREE daily newsletter. Email Address “Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars). CRSP Media Mentions By Week CRSP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRSP News Sentiment▼0.170.37▲Average Medical News Sentiment CRSP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRSP Articles This Week▼148▲CRSP Articles Average Week Get CRISPR Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRSP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Halozyme Therapeutics News Krystal Biotech News Immunovant News Revolution Medicines News ImmunityBio News Iovance Biotherapeutics News SpringWorks Therapeutics News Vaxcyte News Apogee Therapeutics News Arcellx News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRSP) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISPR Therapeutics AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
